Resultados de la búsqueda 31-40 of 6077 for ☃[광고텔레:ADSFIX01] 유심내구제구매 오피홍보 해외선물솔루션홍보 출장 구글1페이지대행 구글웹문서프로그램대행☃

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Patients will be randomized 1:1 into the two arms. Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will ...

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The four cancer types are: Non-Small Cell Lung Cancer (NSCLC) and melanoma that are progressing on checkpoint inhibitor (CPI, generally refers to anti-PD(L)1 ...

3. Terapia de células T con receptor de antígeno quimérico - Mayo Clinic

   CAR-T cell therapy is a cancer treatment that takes cells from the body and genetically changes them so they can fight cancer. It's most often used to treat ...

4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The four cancer types are: Non-Small Cell Lung Cancer (NSCLC) and melanoma that are progressing on checkpoint inhibitor (CPI, generally refers to anti-PD(L)1 ...

5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The four cancer types are: Non-Small Cell Lung Cancer (NSCLC) and melanoma that are progressing on checkpoint inhibitor (CPI, generally refers to anti-PD(L)1 ...

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The four cancer types are: Non-Small Cell Lung Cancer (NSCLC) and melanoma that are progressing on checkpoint inhibitor (CPI, generally refers to anti-PD(L)1 ...

7. Linfoma de Hodgkin (enfermedad de Hodgkin) - Médicos y departamentos - Mayo Clinic

   Departamentos y especialidades. Mayo Clinic tiene uno de los centros médicos más grandes y experimentados en los Estados Unidos, con sedes en Arizona, ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   ... (1) anti-CTLA-4 +/- anti-PD-1/PD-L1, and (2) anti-PD-1/PD-L1 +/- chemo. Secondary Goals. To evaluate the safety of multi-strain probiotic blend in cancer ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The four cancer types are: Non-Small Cell Lung Cancer (NSCLC) and melanoma that are progressing on checkpoint inhibitor (CPI, generally refers to anti-PD(L)1 ...

10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...